Roche’s much-anticipated multiple sclerosis drug Ocrevus (ocrelizumab) has topped up with more competitive data that could help it gain a quick hold in the…

Diabetes powerhouse Sanofi and Verily, its tech partner, are plowing close to $500 million into a joint venture that will take their digital disease-management…

Not enough drugmakers on the “smart inhaler” bandwagon for you? Well, go ahead and add AstraZeneca to the list.

Payers who’ve balked at next-gen cholesterol meds now have more justification. A new JAMA study concluded that Amgen, Sanofi and Regeneron would have to slash…

More and more companies are going “beyond the pill” when it comes to rolling out new products and services that help boost uptake of or compliance with their…

JAMA lit a fuse in pharma last week with a study associating free meals for doctors with increases in branded prescriptions. Here's one marketing expert…

Everyone in healthcare is trying to figure out wearables, including pharma. Omnicom Health Group is counting on a new digital health partnership to help its…

They say there’s no such thing as a free lunch, and for doctors fed by drug companies, the old adage might be true, a JAMA study found.

In the pharma world, waiting room marketing is often overlooked for its sexier DTC cousin. But point-of-care advertising now accounts for about 10% of pharma’s…

Data and Analytics